Clinical trial
Ramipril - Hypertension
NCT00325806 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00325806 |
|---|---|
| Title | Ramipril - Hypertension |
| Official title | Prevention of Hypertension in Patients With High-Normal Blood Pressure With the Angiotensin-Converting-Enzyme-Inhibitor Ramipril - a Randomised Prevention Trial of the German Hypertension League. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Ramipril |
| Enrollment | 1,008 |
| Start date | May 1, 2000 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | May 15, 2006 |
| Last update posted | Mar 8, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: